Jazz Pharmaceuticals

Yahoo Finance • 5 days ago

Top pharmaceutical stocks by Quant to focus on as Novo Nordisk slides

[Close-up of a male hand holding a pill bottle pouring medication into his hand] Trevor Williams The recent news [https://seekingalpha.com/news/4525254-novo-nordisk-slides-as-ozempic-pill-fails-to-slow-alzheimers-disease-progression-in-la... Full story

Yahoo Finance • 5 days ago

Booking, Carvana upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Wedbush upgraded Carvana (CVNA) to Out... Full story

Yahoo Finance • 5 days ago

Here are Monday’s Top Wall Street Analyst Research Calls: Baidu, Carvana, Exact Sciences, Ferrari, Marvell Technology, Meta Platforms and More

mezzotint / Shutterstock.com Quick Read With limited economic data, the Thanksgiving holiday on Thursday, and an early close on Friday, many on Wall Street expect a quieter week than the preceding one. There appears to be a tug-of-war no... Full story

Yahoo Finance • 11 days ago

Zymeworks shifts to a royalty-driven business model

[Golden Percentage Symbol] fatido Zymeworks (ZYME [https://seekingalpha.com/symbol/ZYME]) on Tuesday announced plans to focus on a royalty-driven growth model backed by its internal R&D engine and licensing arrangements with companies suc... Full story

Yahoo Finance • 12 days ago

Stock market today: Dow, S&P 500, Nasdaq slide as sell-off resumes ahead of Nvidia earnings, jobs data

US stocks saw a third day of losses on Monday amid doubts about interest rate cuts, as investors looked ahead to high-stakes Nvidia (NVDA) earnings and the delayed September jobs report. The tech-heavy Nasdaq Composite (^IXIC) erased mode... Full story

Yahoo Finance • 12 days ago

Stocks making the biggest moves midday: Brinker International, Alphabet, Quantum Computing & more

Check out the companies making the biggest moves midday: Brinker International — The Chili's parent jumped more than 8%, on pace for its largest one-day advance since April. Short interest amounts to 12% of Brinker's float, FactSet data sh... Full story

Yahoo Finance • 12 days ago

Stock Market Today: S&P 500, Nasdaq Recover After Weak Start to Week

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Monday. This is TheStreet’s Stock Market Today for Nov. 17, 2025. You can... Full story

Yahoo Finance • 12 days ago

Biggest stock movers Monday: GOOG, DELL, QUBT, XPEV, and more

[A blue financial chart with arrows pointing up] Olena_T Stock futures inched lower on Monday, signaling a cautious start to the week. Investors are anticipating a renewed stream of official U.S. economic data releases, delayed by the rec... Full story

Yahoo Finance • 12 days ago

Stocks making the biggest moves premarket: Alphabet, Zymeworks, lithium producers, Quantum Computing, Clearwater Analytics and more

Check out the companies making headlines in premarket trading. Alphabet — The YouTube and Google owner rose more than 4% after Warren Buffett's Berkshire Hathaway revealed it took a more than $4 billion stake in Alphabet in the third quart... Full story

Yahoo Finance • 12 days ago

Jazz, Zymeworks’ Ziihera trial shows significant PFS improvement, shares rally

[Biomedical Researchers Conduct Experiments in a Modern Laboratory. Female Scientist Preparing a Set of Samples in Test Tubes with Purple Caps. Colleague Analyzes Data on a Computer in the Background] gorodenkoff/iStock via Getty Images... Full story

Yahoo Finance • last month

Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors

Dr. Love, a biopharmaceutical industry veteran, brings extensive executive leadership and board experience with proven success in creating shareholder value DUBLIN, Oct. 28, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) tod... Full story

Yahoo Finance • last month

Basal Cell Nevus Syndrome Market Growth Accelerates with Novel Therapies and Clinical Developments | DelveInsight

The basal cell nevus syndrome market is expected to witness steady growth driven by increasing awareness, advances in targeted therapies, and the development of novel hedgehog pathway inhibitors. Additionally, the expected launch of emergi... Full story

Yahoo Finance • last month

Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement

Avadel Pharmaceuticals plc DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all... Full story

Yahoo Finance • last month

First Week of June 2026 Options Trading For Jazz Pharmaceuticals (JAZZ)

Investors in Jazz Pharmaceuticals plc (Symbol: JAZZ) saw new options become available this week, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so wi... Full story

Yahoo Finance • 2 months ago

Jazz Pharmaceuticals plc (JAZZ) Wins FDA Nod for Modeyso in Rare Pediatric Brain Tumors

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Jazz Pharmaceuticals plc stands ninth among them. Jazz Pharmaceuticals plc (NASDAQ:JAZZ), a global biopharmaceutical leader, develops and commercializ... Full story

Yahoo Finance • 3 months ago

Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem

[FDA Seal of Approval and Rubber Stamp] asbe/iStock via Getty Images Amneal Pharmaceuticals (NASDAQ:AMRX [https://seekingalpha.com/symbol/AMRX]) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved its generic p... Full story

Yahoo Finance • 3 months ago

Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More

Company Logo The global chronic myelomonocytic leukemia (CMML) market is set for significant growth due to rising CMML cases, advanced targeted therapies, and increased disease awareness. Recognized as a rare leukemia, CMML's prevalence,... Full story

Yahoo Finance • 3 months ago

Jazz Pharmaceuticals Enters Into Global License Agreement To Develop SAN2355

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ), Wednesday announced a global license agreement with Denmark-based Saniona to obtain exclusive worldwide rights to develop SAN2355, a preclinical, selective small molecule activator for epilepsy... Full story

Yahoo Finance • 3 months ago

Ligand to Participate in September Investor Conferences

JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcom... Full story

Yahoo Finance • 4 months ago

BofA Securities raises Jazz Pharmaceuticals stock price target on Modeyso potential

Investing.com - BofA Securities has raised its price target on Jazz Pharmaceuticals (NASDAQ:JAZZ) to $225.00 from $217.00 while maintaining a Buy rating ahead of the company’s upcoming investor webcast. The new target aligns with the broad... Full story